Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Therapy

by Justina Yick Ching Lam MBBS, MRCP, Matthew Chau Hsien Ng MBBS, MRCP, PhD
Published 2014-09-01

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

by Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Xuan En Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh, Qi Zeng
Published 2019-06-01